Microbot Medical® Granted Multiple New Patents, Further Strengthening Its Global Intellectual Property Portfolio
Microbot Medical received several new patent approvals across the U.S., Japan, China and Canada, bringing its portfolio to 44 issued patents and 49 pending applications. The company says the strengthened IP estate supports commercial expansion of its LIBERTY Endovascular Robotic System in the U.S. and positions it for EU market entry as it pursues a CE Mark.
Key figures
- Issued patents
- 44
- Pending patents
- 49
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.